These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20433799)

  • 21. [Diagnosis, treatment, and prophylaxis for cytomegalovirus disease following allogeneic stem cell transplantation].
    Gondo H
    Rinsho Ketsueki; 2003 Dec; 44(12):1154-60. PubMed ID: 14978931
    [No Abstract]   [Full Text] [Related]  

  • 22. Concurrent blinatumomab and donor lymphocyte infusions for treatment of relapsed pre-B-cell ALL after allogeneic hematopoietic cell transplant.
    Ueda M; de Lima M; Caimi P; Tomlinson B; Little J; Creger R; Lazarus H; Cooper B
    Bone Marrow Transplant; 2016 Sep; 51(9):1253-5. PubMed ID: 27088374
    [No Abstract]   [Full Text] [Related]  

  • 23. Donor chimerism does not predict response to donor lymphocyte infusion for relapsed chronic myelogenous leukemia after allogeneic hematopoietic cell transplantation.
    Chiorean EG; DeFor TE; Weisdorf DJ; Blazar BR; McGlave PB; Burns LJ; Brown C; Miller JS
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):171-7. PubMed ID: 14993882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Donor leukocyte infusions after unrelated donor hematopoietic stem cell transplantation.
    Loren AW; Porter DL
    Curr Opin Oncol; 2006 Mar; 18(2):107-14. PubMed ID: 16462177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allogeneic peripheral blood progenitor cell (PBPC) transplantation in children.
    Villa M; Madero L; Diaz MA; Alegre A; Granda A; Velasco M; Vicario JL
    Bone Marrow Transplant; 1996 Jul; 18(1):231-3. PubMed ID: 8832024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation.
    Mori T; Mori S; Kanda Y; Yakushiji K; Mineishi S; Takaue Y; Gondo H; Harada M; Sakamaki H; Yajima T; Iwao Y; Hibi T; Okamoto S
    Bone Marrow Transplant; 2004 Feb; 33(4):431-4. PubMed ID: 14676775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of transplantation regimen on prognostic significance of high-level minimal residual disease before allogeneic stem cell transplantation in children with ALL.
    Schneider M; Hettinger K; Matthes-Martin S; Konrad M; Peters C; Gadner H; Panzer-Grümayer ER
    Bone Marrow Transplant; 2001 Dec; 28(11):1087-9. PubMed ID: 11781621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemopoietic stem cell transplantation from a donor with indeterminate HTLV-1 status.
    Au WY; Chan E; Lie AK
    Am J Hematol; 2007 Jun; 82(6):495. PubMed ID: 16929539
    [No Abstract]   [Full Text] [Related]  

  • 29. Early viral complications after autologous CD34-selected peripheral blood stem cell transplantation.
    Sica S; Sora F; Chiusolo P; Laurenti L; Cattani P; Giordano G; Piccirillo N; Ortu La Barbera E; Leone G
    Bone Marrow Transplant; 2000 Sep; 26(5):587-8. PubMed ID: 11019854
    [No Abstract]   [Full Text] [Related]  

  • 30. Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia.
    Elliott MA; Tefferi A; Hogan WJ; Letendre L; Gastineau DA; Ansell SM; Dispenzieri A; Gertz MA; Hayman SR; Inwards DJ; Lacy MQ; Micallef IN; Porrata LF; Litzow MR
    Bone Marrow Transplant; 2006 Jun; 37(11):1003-8. PubMed ID: 16604096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endoscopic evaluation for cytomegalovirus enterocolitis after allogeneic haematopoietic stem cell transplantation.
    Kakugawa Y; Kami M; Kozu T; Kobayashi N; Shoda H; Matsuda T; Saito Y; Oda I; Gotoda T; Mori S; Tanosaki R; Murashige N; Hamaki T; Mineishi S; Takaue Y; Shimoda T; Saito D
    Gut; 2006 Jun; 55(6):895-6. PubMed ID: 16698757
    [No Abstract]   [Full Text] [Related]  

  • 32. Relapsed diffuse large B-cell lymphoma treated by reduced-intensity allogeneic stem cell transplantation with donor lymphocyte infusion.
    Chaudhry QU; Ahmed P; Ullah K; Satti TM; Raza S; Mehmood SK; Akram M; Ahmed S
    J Coll Physicians Surg Pak; 2010 Mar; 20(3):211-3. PubMed ID: 20392389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Capsule endoscopy as a diagnostic tool in the evaluation of graft-vs.-host disease.
    Silbermintz A; Sahdev I; Moy L; Vlachos A; Lipton J; Levine J
    Pediatr Transplant; 2006 Mar; 10(2):252-4. PubMed ID: 16573617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Donor peripheral stem cells infusion for the treatment of failure of platelet recovery after allogeneic hematopoietic stem cell transplantation].
    Chen Y; Xu LP; Liu DH; Chen YH; Han W; Shi HX; Zhang XH; Wang JZ; Chen H; Liu KY; Huang XJ; Lu DP
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):964-6. PubMed ID: 17650420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response.
    Jones SC; Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2003 Apr; 9(4):243-56. PubMed ID: 12720217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure.
    Nakamura R; Battiwalla M; Solomon S; Follmann D; Chakrabarti S; Cortez K; Hensel N; Childs R; Barrett AJ
    Biol Blood Marrow Transplant; 2004 Jan; 10(1):49-57. PubMed ID: 14752779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A rare cause of ulcerative colitis - diarrhoea and perianal bleeding due to posttransplant lymphoproliferative disorder (PTLD).
    Godt C; Regnery A; Schwarze B; Junker K; Porschen R
    Z Gastroenterol; 2009 Mar; 47(3):283-7. PubMed ID: 19280542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of cytomegalovirus (CMV) infection in allogeneic hematopoietic stem cell recipients at low risk of CMV infection.
    Mori T; Okamoto S; Watanabe R; Yamazaki R; Tsukada Y; Nagayama H; Ishida A; Ikeda Y
    Bone Marrow Transplant; 2002 Jun; 29(12):1005-6. PubMed ID: 12098071
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and related risk factors].
    Huang XJ; Xu LP; Ren HY; Zhang YC; Guo NL; Lu DP
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):766-9. PubMed ID: 12899755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of human cytomegalovirus infection UL55-nested polymerase chain reaction method in hematopoietic stem cell transplant donors and recipients.
    Banan AA; Yaghobi R; Ramzi M; Mehrabani D
    Transplant Proc; 2009 Sep; 41(7):2898-9. PubMed ID: 19765467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.